Home
Conditions
Gliosarcoma

Clinical trial condition

Gliosarcoma

Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.

373 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Gliosarcoma trial results

Recruiting

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

NCT05756985

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations: Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States

View Trial Details

Recruiting

Study of Pembrolizumab and M032 (NSC 733972)

NCT05084430

Conditions: Anaplastic Astrocytoma, Astrocytoma, Disease Attributes, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

NCT05465954

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Recruiting

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT04541082

Conditions: Anaplastic Astrocytoma, Anaplastic Meningioma, Anaplastic Oligodendroglioma, +41 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Not yet recruiting

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

NCT07422363

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: Not specified

View Trial Details

Active, not recruiting

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

NCT03197506

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Active, not recruiting

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

NCT03115333

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States

Mayo Clinic Hospital Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Eden Hospital Medical Center Castro Valley, California, United States

View all 58 locations

View Trial Details

Active, not recruiting

Pembrolizumab in Treating Patients With Recurrent Glioblastoma

NCT02337686

Conditions: Astrocytoma, Glioblastoma, Glioma, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

NCT05039281

Conditions: Astrocytoma, Glioblastoma, Glioma, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

NCT00268385

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

UCSF Medical Center-Mount Zion San Francisco, California, United States

Moffitt Cancer Center Tampa, Florida, United States

View all 17 locations

View Trial Details

Gliosarcoma

Gliosarcoma trial results

Related conditions